24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2022
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2022 VC Survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Weekly Roundup
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
19:28
Full list of Israeli high-tech funding rounds in 2024
19:24
TailorMed raises $40 million in equity and debt to help patients access critical medications
18:17
Why Israeli tech companies are moving to Miami
17:11
Mediaocean acquires Innovid for $500M, delisting it from the NYSE
More stories
Buzz
Most popular
Daily
Weekly
1
Wiz acquires Dazz for $450 million to strengthen AI-driven cloud security
2
Cyera doubles valuation to $3B with $300M Series D, total funding hits $600M in seven months
3
Claroty veterans launch Twine with $12M in Seed funding from Dell and Wiz founders to deploy AI cyber workers
4
Mediaocean acquires Innovid for $500M, delisting it from the NYSE
5
Prompt Security raises $18 million Series A to protect enterprises from GenAI risks
More news
Weekly Roundup
4 stories about Weekly Roundup
CTech’s Weekly Roundup of Israeli Tech News
13.04.18
|
CTech
In Israeli tech, women are worth half as much as men. Israel set to approve export of cannabis
CTech’s Weekly Roundup of Israeli Tech News
23.03.18
|
CTech
KLA-Tencor buys electronics manufacturing equipment Orbotech for $3.4 billion. Company behind AMD vulnerabilities report denies ties to short selling outfit
CTech’s Weekly Israeli Tech News Roundup
23.02.18
|
CTech
Intel plans to expand chip manufacturing in Israel with $5 billion investment. Latest venture by Mobileye founders valued at $1 billion. Intel leads $50 million investment in public transit app Moovit.
CTech’s Weekly Israeli Tech News Roundup
01.12.17
|
CTech
Amazon’s plans to open local distribution center, Uber’s retreated after facing legal pressure, and Teva is going back to its roots
Please ensure Javascript is enabled for purposes of
website accessibility